DNA Compass uses advanced mapping technology to connect individuals to specific locations on the genome, driving progress in genetic research and accelerating cures.

How It Works: Patients select a trusted entity to securely host their genome. This entity converts the patient’s genomic data into a secure map layer, enabling bidirectional communication tools for identifying genetic markers and fostering collaboration between patients and researchers.

Patient-Driven Research: Advocacy groups can empower their members by converting genomes into actionable maps that highlight key genome hotspots and top gene clusters.
Patients can then match their genetic profiles to clinical trials.
‍Research and Industry Access: Researchers gain access to federated global genomic data through an open API, streamlining data exchange and improving trial outcomes.

Tools for Patient Engagement
‍

We place patient advocacy and engagement at the core of our research collaborations:

• For Advocacy Groups: Our platform integrates ClinGen and ClinVar databases, providing accurate, up-to-date genomic information to enhance patient decision-making. We prioritize Genomic Privacy and Data Sovereignty, ensuring that individuals control their genomic data. By incorporating PCORI principles, we empower patients through patient-reported outcomes, real-world evidence, and genomic insights. We collaborate with organizations like NORD to support rare disease diagnosis, treatment, and advocacy.
• For Industry: We facilitate faster, broader research by enabling secure access to federated data using FHIR, GA4GH, and HL7 standards. This ensures interoperability and efficient data exchange. Additionally, leveraging AI tools like AlphaFold, we enhance genomic research to accelerate discoveries in personalized medicine, drug development, and disease modeling, while supporting initiatives like the NIH's "All of Us" Research Program.

Building Global Research Capacity

By repurposing a country’s existing earth mapping infrastructure, DNA Compass provides:

• Revocable Data Access and Consent: Our platform is designed with patient and community-centered security, allowing revocable data access and informed consent. We uphold Data Sovereignty, ensuring individuals and communities maintain control over their genomic and health data while enabling secure, ethical research collaborations.
• Open API Integration: With a fully open API, our system seamlessly integrates with existing healthcare infrastructures. By leveraging FHIR (Fast Healthcare Interoperability Resources) standards, we ensure interoperability, secure data exchange, and enhanced patient engagement across diverse healthcare ecosystems. We also follow GA4GH guidelines to maintain privacy while facilitating collaborative genomic research.
• AI and ML Integration: Leveraging cutting-edge AI-driven technologies like AlphaFold, we enhance genomic research by predicting protein structures with unprecedented accuracy. This integration accelerates discoveries in personalized medicine, drug development, and disease modeling. Additionally, we actively support large-scale initiatives like the NIH’s "All of Us" Research Program, contributing to a more inclusive understanding of human genomics through diverse population studies.

Promoting Genomic Literacy
‍

DNA Compass offers tools to improve genomic understanding through verified entities:

• Private and Hybrid Clouds: Our HIPAA-compliant services ensure data privacy and security while facilitating efficient genomic research.
• Dynamic Genome Mapping: We provide real-time updates to genome maps, dashboards, and reports to enhance data visualization and decision-making.
• Role-Based Security: Content delivery is tailored based on user type, ensuring relevant and secure access to genomic information.
  We align with global initiatives, including UNESCO, to promote ethical genomic research, education, and data governance, ensuring responsible data sharing and advancing science for the benefit of all.